Funding will help early stage companies commercialize new technologies.
The Kansas Bioscience Authority (KBA) has announced investments in six Kansas City-area companies. The investments totaling more than $2 million will help those companies to commercialize innovative bioscience technologies that will improve human and animal health, the KBA said.
“These companies are on the cutting edge of their fields, and their technological advances are very exciting,” said David Vranicar, KBA president. “We are pleased not only to invest in their success, but also to roll up our sleeves and help them get products to market and create jobs in Kansas.”
To read the full, original article click on this link: Thinking Bigger Business Media - KBA Invests $2 Million in Area Bioscience Companies
